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Abstract
Background: Physicians are usually at the forefront when the issue of driving ability is raised by Parkinson’s disease
(PD) patients or their family members, even though few have been formally trained in this area.
Objectives and methods: To identify relevant literature on driving assessment tools in patients with PD by
performing a systematic review on this subject in order to provide background information for physicians on what
types of driving assessment are available, and to delineate the role of physicians in providing fitness to drive
recommendations.
Results: Of 1,490 abstracts screened, 55 articles fulfilled the selection criteria that investigated assessment of driving
ability in PD patients with questionnaires, off-road testing battery, driving simulators, and driving skill tests (on-road
tests and naturalistic driving test). Despite different methodology across studies, PD patients were observed to
commit more driving errors than controls. Poor driving performance correlated with motor, visual, and cognitive
severity. Excessive daytime somnolence was common in PD drivers and the presence of falling asleep while driving
was identified to be a significant predictor of car accidents.
Conclusion: Although the evidence indicated more driving errors among PD drivers as identified by various
assessment tools, the extent on how physicians should be involved in the evaluation process and make related
recommendations remain unclear. Driving safety is an important public health issue in PD that needs better-defined
specific legal and medical guidelines. National guidelines that establish risk assessment protocols involving
multidisciplinary assessments are needed to assist physicians in making appropriate referrals for additional
evaluations and recommendations when patients are deemed to be unsafe drivers.
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Introduction
Driving a motor vehicle is a complex task that requires
cognitive functions for decision-making and multi-level
integration of sensory, motor, and cortical functions.
Parkinson’s disease (PD) patients have impairment in
both motor and cognitive ability that could lead to poor
driving performance. Driving competence is, therefore,
of great concern to PD patients, their families, health-
care professionals, and those with the responsibility of
promoting and protecting public safety. As driving is an
important activity of daily living for PD patients who
rely on a vehicle for shopping and medical appoint-
ments, determination of driving competency in PD is
essential and this determination requires a reliable as-
sessment tool. Although the decision making process re-
garding fitness to drive is not entirely the responsibility
of the physician, the issue of driving competency is often
first raised by patients or family members during phys-
ician consultations. In response, physicians often feel
uncomfortable providing recommendations due to a lack
of established practice parameters or guidelines. Accord-
ingly, this study set forth to conduct a review of the
literature to identify the driving evaluations that are cur-
rently available and to provide practical recommen-
dations to physicians regarding options and strategies
they can discuss with PD patients when encountering
the issue of determining fitness to drive.
Review
The term “human mobility” is defined as a person being
able to travel where and when he or she wants [1].
Fulfillment of mobility interests and desires produces
physical, psychological, and social benefits, with private
driving for many representing the ultimate in private
mobility [1]. For those who drive, driving represents
independence, self-reliance, freedom, and self-control. In
contrast, loss of the ability to drive directly affects an in-
dividual’s mobility and this is associated with a number
of negative consequences, including reduced outdoor
activity, altered personal identity, decreased life satisfac-
tion, increased depression, and increased dependence on
family members or caregivers for assistance with trans-
portation [2].
Driving a car is a highly complicated task that is per-
formed in a constantly changing environment and that
involves integration of perception, information process-
ing, attention, decision-making, motor programming,
executive function, and concurrent task management [3,
4]. According to the driver behavior model proposed by
Michon in 1985, drivers need to simultaneously conduct
problem solving tasks that are divided into three levels
of skill and control including: strategic (planning), tac-
tical (maneuvering), and operational (control) levels
(Fig. 1a) [5]. The strategic level is defined as general
route planning, while the tactical and control levels in-
volve individual responsiveness to driving circumstances
with controlled or automatic action patterns respect-
ively. Unsafe driving is defined as operating a motor
vehicle in an unsafe manner, which often results in
traffic-related violations [6].
Effect of medical illness and Parkinson’s disease on
driving ability
When determining fitness to drive in the elderly, the
effect of aging needs to be considered as it can adversely
affect driving competency with increased risk of unsafe
driving, accidents, and injury [7–9]. According to the
Global Status Report on Road Safety 2015, traffic
Fig. 1 The model of driving behavior proposed by Michon (5). a The model of normal driving based on Michon’s driving behavior model. Drivers
utilize three levels of skills in vehicle control: strategic (planning), tactical (maneuvering), and operational (control). Visual, cognitive, and motor
skills are required for operations at tactical and operational levels of driving whereas visual skills are generally not required for operation at the
strategic level of driving. b The model of driving behavior in Parkinson disease (PD) patients. PD compromises motor, visual, and cognitive
performances in affected individuals. As a result, it is proposed that PD drivers have impairment of driving performance at all levels (operational,
tactical and strategic levels). However, the severity varies with individual patients
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accidents involving the elderly represent 1 out of 6 of
the total of 1.2 million people who die worldwide each
year in road traffic accidents [10]. Statistics from the US
National Highway Traffic Safety Administration similarly
reported that 16 % of all licensed drivers were 65 years
and older who represented 17 % of all traffic fatalities
[11]. These data illuminate the existential risks associ-
ated with driving among elderly drivers. However, the
effect of aging is unlikely to be the sole reason for
decreased driving competency among the elderly, given
that neurological comorbidities, such as stroke, demen-
tia, and PD, are common in this population. While exist-
ing data establishes the fact that patients with stroke and
dementia are at significantly greater risk of road traffic
accidents than age-matched controls, the evidence
regarding the ability to drive among PD patients has
started to accumulate and the findings show that they
are also at substantially greater risk of unsafe driving
[12–14]. Indeed, PD has recently been identified as one
of the factors, together with old age and dementia, to be
associated with driving restrictions in elderly men and
women [7, 15]. Moreover, the presence of comorbidities
in PD patients (e.g., heart and vascular diseases, eye
problems, and other neurological disorders) can further
compromise a patient’s driving ability, thus revealing an-
other influential factor for physicians to consider when
determining driving competency [16–18].
According to the driver’s behavior model, it is plaus-
ible that PD patients have impairment in all strategic,
tactical, and operational levels (Fig. 1b). Motor deficits
(e.g., bradykinesia, rigidity, tremor, and dyskinesia) may
affect vehicle control (operational level) while non-
motor deficits (e.g., cognitive decline, neuropsychiatric
symptoms, and visual impairment) may impair route
planning – both of which result in driving errors (stra-
tegic and tactical levels). This assertion is supported by
numerous studies showing that PD drivers performed
worse on testing of contrast sensitivity, cognition, sleepi-
ness, and reaction time, when compared to controls [3,
19–23]. These poor performances in various domains
are likely to influence their driving practices. For ex-
ample, slowness in cognitive functions, including pro-
cessing, choice reaction time, visual perception, and
memory, have been identified as key factors that affect
driving in PD patients [3]. One study indicated that up
to 21 % of PD patients (32 out of 150 patients) stopped
driving as soon as their diagnosis was made, mostly due
to safety concerns (18.7 %). Interestingly, only 1.3 % (2
out of 150 patients) quit driving based on physicians’
recommendations [12]. In a large survey involving more
than 5,000 patients with PD, one-third of patients
reportedly restricted their driving in terms of reduced
distance and trip duration due to their parkinsonian
symptomatology, sleepiness, the effort required, and
potential dangers [24]. They were also less likely to drive
at night, in peak traffic, long distances, or alone [14]. As
a result, about 18 % of PD patients who actively drove at
baseline assessment ceased driving two years later, in
comparison to only 3 % of control group drivers who
stopped driving over the same period [25]. While earlier
reports suggested that PD drivers had an increased risk
of crashes per million miles traveled, one recent study
yielded contradicting results indicating that PD drivers
do not have a higher prospective risk of car crashes or
incur a higher number of traffic violations compared to
controls, which may be partly due to their restricted
driving practices and a lower number of PD patients
who continue to drive [12, 25]. Decreased driving ability
and patient perception of their poor driving performance
are likely to contribute to social isolation, sedentary life-
style, and depression. As such, there is a need for physi-
cians to identify patients who are at-risk and recommend
them for regular driving assessment, driving retraining, or
rehabilitation, if indicated and available. Identified from
this systematic review, Table 1 provides a list of ‘red flags’
that will alert physicians on which patients should be eval-
uated for fitness to drive.
Who determines fitness to drive in Parkinson’s disease
patients?
Fitness to drive protocols vary greatly from country to
country. While no uniform international standard exists,
Table 1 The list of “red flags” that should alert the physician
about PD patient’s fitness to drive
Methods Red flags
1. Clinical history • History of car accident (during the past 5 years)
• Presence of sleep attacks while driving
• High daily levodopa equivalent dosage≥
585 mg
• Long disease duration≥ 8 years
2. Questionnaire • High Epworth sleepiness scale (ESS score≥ 10)
3. Motor assessment • High H&Y score≥ 2.5 points
• High UPDRS motor score > 27 points
• High rapid pace walk score≥ 6.22 points
• High Webster’s scale
4. Cognitive
assessment
• Low MMSE score < 27 points or low MOCA
score
• Poor performance on Trail A&B making test
• Poor performance on complex figure test
• Poor performance on block design test
• Poor performance on dot cancellation test
5. Visual assessment • High UFOV risk index≥ 3
• Poor performance on Pelli-Robson contrast
sensitivity
• Poor visual acuity
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medical standards for driver licensing and physician’s
guidelines for assessment of fitness to drive have been
established in some countries, including the United
States (American Medical Association and The National
Highway Traffic Safety Administration), Canada (Canadian
Medical Association), United Kingdom (Driver and Vehicle
Licensing Agency), and Australia (National Transport
Commission) [26–30]. Roles and responsibilities of drivers,
health professionals, and driver licensing authorities have
been proposed. While drivers have a responsibility to self-
assess driving abilities and report any permanent injury or
illness that may affect their ability to drive safely, health
professionals have an ethical and legal duty to maintain pa-
tient confidentiality and must have legal justification for
breaching that trust in cases where an unfit driver may
pose a threat to public safety. Physicians that evaluate for
fitness to drive and that identify a condition that may
impair driving performance are obligated to report that
finding to driver’s licensing authorities [26, 27]. The driver
licensing authority is then tasked with the responsibility of
deciding whether to license a driver or not, based upon
the driver’s health report, driving performance record, and
violation history.
Although risk determination may ultimately be the re-
sponsibility of licensing authorities, health professionals
are generally responsible for recommending to licensing
authorities whether individuals with medical conditions
should be permitted to drive (with or without restric-
tions) [31]. Although guidelines have been published for
health professionals regarding how to assess fitness to
drive among drivers with underlying neurological disor-
ders, most of those guidelines do not propose disease-
specific tests, regulations, and severity of symptoms that
would designate someone as an “unsafe driver”. This as-
pect is particularly important as patients with different
diseases are likely to perform differently in their driving
due to specific limitations caused by their underlying
disorders. Although driving regulations have been estab-
lished for epilepsy patients (UK: license is usually re-
stored if there have been no seizures for 5 years and no
other disqualifying condition, Australia: at least an an-
nual evaluation for a conditional license for the epileptic
patients who had no seizure for 12 months and stayed
well with adherence to medications) and dementia pa-
tients (discontinuing driving if Clinical Dementia Rating
scale is of 1 or above for patients with Alzheimer’s dis-
ease), no specific regulations have been implemented in
patients with PD [6, 28, 32, 33]. The National Transport
Commission of Australia recommends that physicians
assess motor and cognitive functions of PD drivers, their
response to antiparkinsonian medications, and monitor
their symptoms every 12 months, but no specific course
of action has been proposed for unsafe PD drivers [28].
Recently, a consensus statement was proposed for
occupational therapy practitioners and driver rehabilita-
tion specialists stating that PD patients with mild motor
disability may be fit to drive with a recommendation for
annual comprehensive driving evaluation while those
with severe disease severity should discontinue driving
[34].
Driving evaluations in Parkinson’s disease patients: a
physician’s role
In clinical practice, the first tier in the decision-making
process of determining fitness to drive involves the treat-
ing physician (family physician or neurologist) when the
issue of driving competency is raised by either family
members or patients themselves on various occasions,
for example when they are first diagnosed with PD or
when they observe the effect of parkinsonian symptoms
on their driving abilities [24]. At this stage, the physician
is often asked to make an assessment regarding whether
the patient is medically fit to drive, even though physi-
cians are not trained in this area and current evaluation
methods for determining driving ability in people with
medical conditions or disabilities are very subjective,
with information usually provided by patients, family/
caregivers, and/or attending physicians [35]. While it is a
physician’s legal responsibility in some countries or
states to report unsafe PD drivers to the local author-
ities, this often becomes a point of conflict between
physicians and patients, as evidenced by one survey indi-
cating that while 77 % of physicians discussed driving
with their patients, only 14 % of physicians reported pa-
tients to licensing authorities for further evaluation of
driving competency [31]. It is also not surprising that
one survey found a significant lack of knowledge among
physicians regarding assessment for fitness to drive [36].
As one would expect, early-stage PD patients have less
driving impairment than advanced-stage PD patients,
but many early-stage drivers have difficulty accurately
assessing their level of driving competency and some
early-stage patients give up driving earlier than necessary
[37]. Conversely, some advanced-stage PD patients who
are at-risk to drive consider themselves fit to drive [3].
Classifying all individuals diagnosed with PD as an “un-
safe driver” and preventing them from driving is not ad-
visable due to the finding that a loss of driving privileges
has been associated with psychological consequences
that vary by patient [38, 39]. As such, we are faced with
the challenge of finding a balance between what is best
for the patient and what is best for the public. More spe-
cifically, we should become aware of tests and assess-
ment protocols that accurately measure fitness to drive
so that the best interest and safety of both PD patients
and the general public can be protected.
In the medical literature, there are four main methods
used for the evaluation of driving ability in PD patients,
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including questionnaires, off-road tests (clinical assess-
ment and others), driving simulator, and driving skill
tests (an on-road test and naturalistic driving) (Table 2).
Different types of questionnaires were developed to
assist physicians in their evaluation [12, 24, 40, 41].
However, there is poor correlation between patient ques-
tionnaires and disease severity scales in determining
medical fitness to drive [12]. This discrepancy necessi-
tates physicians to consider additional tests that evaluate
driving-related skills and abilities, including vision,
cognition, motor/somatosensory function, and neuro-
psychological testing (the so-called ‘off-road testing bat-
tery’) (Table 2) [6, 27, 28, 30]. While a combination of
motor, visual, and cognitive assessments is often consid-
ered an adequate tool that determines functional ability
of elderly drivers, it does not evaluate driving skills and
does not predict the possibility of accidents in this popu-
lation [26]. Due to a lack of standardized parameters and
protocols for the different off-road testing methods, off-
road tests alone cannot reliably predict actual driving
performance or the likelihood that a PD patient is or will
be at risk for a driving-related accident. Further, positive
off-road testing results are not sufficient for designating
someone an “unsafe driver” or recommending them for
driving cessation [26]. Therefore, comprehensive driving
evaluations often include on-road testing, which is con-
sidered to be the reference standard and the ultimate
form of driving assessments (Table 2) [42, 43].
Driving simulator determines driving abilities by pro-
viding driving stimuli and assessing driving responses in
various challenging, but safe environments [44]. The in-
clusion of driving simulator as part of a comprehensive
off-road test has been found to increase sensitivity and
specificity of an off-road test in predicting pass/fail sta-
tus of PD drivers on an on-road test [19]. Therefore,
driving simulator may be an option for physicians to
consider in patients who need driving evaluation but are
deemed not to be suitable candidates for on-road testing
for various reasons (Table 2). However, the testing pro-
tocols of driving simulators have not been standardized
and their validity against actual road driving has not
been established [44].
Table 2 Driving assessment tools in Parkinson’s disease
Types Testing methods Advantages Disadvantages
Questionnaires and structure
interviews
• Structured interview [53–55, 58]
• The Epworth Sleepiness Scale [24,
40, 41, 56, 57, 59–61]
• Restless legs syndrome
questionnaire [61]
• The sudden onset of sleep
questionnaire [24]
• SCOPA-sleep scale [62]
• Suitable for screening a large
number of patients in a short
period of time
• Cost effective
• Ability to capture subjective
symptoms, e.g., sleepiness
• No risk for physical injury during
the test
• Lack specificity
• Potential bias during recruitment.
[12]
• Findings may not be conclusive for
final recommendations on driving.
Off-road testing battery • Motor assessment (HY, UPDRS-
motor, Webster’s scale, rapid pace
walk, disease duration, LEDs, etc.)
[4, 21, 25, 37, 75, 77, 82, 88, 91]
• Cognitive assessment (MMSE, Trail
making test, Complex figure test,
Dot cancellation, block design test,
etc.) [13, 67, 69, 74–76, 80, 83, 84,
86, 88, 91]
• Visual assessment (UFOV) [13, 25,
75, 80, 82, 84, 91]
• The tests provide clinical
information of patients on their
ability in motor, cognitive and
visual domains.
• Some jurisdictions use an off-road
evaluation to predict on-road
behavior [27]
• No risk for physical injury.
• Findings may not be conclusive for
final recommendations on driving.
• Findings are limited to clinical
information on individual patients,
not his/her driving performance.
Driving simulators • Various types of driving simulators
[4, 19, 20, 37, 63–74].
• Ability to control and standardize
testing conditions and methods
• Various outcome parameters can
be implemented.
• Patients are not exposed to
significant risk associated with
on-road tests.
• No standardized protocols
• Simulator sickness
• Testing scenarios are not real.
On-road tests • An on-road test with/without
instrument vehicle, and accompanied
with a driver instructor for rating
the driving score [3, 13, 14, 19, 21, 25,
74–91].
• Considered as a gold standard
driving test for licensing new
drivers by most authorities [43, 86]
• Provided realistic driving test
• Standardized outcome parameters
• Potential physical injuries and
accidents during the tests
• Unfamiliar testing scenarios
• Not suitable for patients with
physical limitations or handicaps
Naturalistic driving • An attached devices equipped in a
patients’ own car for collection of
driving data [23, 92, 93].
• The most realistic driving test with
familiar environment
• Potential physical injuries and
accidents during the tests
• Potential risk imposed to others on
the road
• No standardized testing protocols
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In an on-road test, patients drive on a real, predeter-
mined road course for 45–60 min with a Certified Driving
Rehabilitation Specialist (CDRS), advanced-specialized oc-
cupational therapist, or driver rehabilitation specialist that
observes from the passenger seat [45, 46]. The observer is
responsible for assessing patient driving performance,
maintaining vehicle safety, and rating driving outcomes in
a Global Rating Score (GRS) and a Sum of Maneuver
Score (SMS). The GRS has 4 outcome grades, including
pass, pass with recommendations, fail with potential for
remediation, and fail. Although on-road tests are consid-
ered as the reference standard, there are certain draw-
backs, including availability, an inadequate amount of
safety assurance for at-risk patients, and potentially inad-
equate testing resources for PD patients that need to be
re-tested and re-certified each year [42, 43]. The on-road
test observer can provide both a comprehensive evalu-
ation of driving skills and recommendations for car modi-
fications or tools to keep someone driving safely for as
long as possible [46, 47].
Naturalistic driving, also known as naturalistic obser-
vation, is a new method for evaluating driving skills and
abilities. Naturalistic driving longitudinally monitors un-
safe behaviors via instrumentation in naturalistic driving
settings [48–51]. Naturalistic observation typically in-
volves the use of the patient’s car, which is equipped
with devices that continuously monitor various aspects
of driving behavior, including information about vehicle
movement, the driver, and the natural driving environ-
ment. This assessment method makes it possible to
observe and analyze the interrelationship between the
driver, and the vehicle, road, and other traffic in normal
situations, conflict situations, and actual collisions [52].
Systematic review of assessment tools for determining
fitness to drive in Parkinson’s disease patients
The aim of this study was to perform a systematic re-
view of the four main driving assessment methods
(questionnaires and structured interview, off-road tests,
driving simulator, and driving skill tests) and provide the
evidence on individual methods for assessing driving
ability in PD patients. To address the question of how
much evidence we have regarding driving competency in
PD, we performed a systematic review by searching
MEDLINE, life science journals, Google scholar, and on-
line books using the following key words: driving OR
driving safety OR driving ability OR road test OR driving
questionnaires OR sleepiness scale OR driving simulator
OR naturalistic driving OR car sensor OR reaction time
OR driver OR transportation OR automobile OR car OR
vehicle OR collision injury OR car accident. Selected
articles were required to have the term “Parkinson’s
disease” AND any one of the above key words within the
title and/or abstract.
A targeted search of the bibliographies of relevant arti-
cles was also performed to identify any additional studies
for inclusion. Only original, full-text articles published in
English between January 1973 and April 2016 that
assessed methods for determining driving ability in PD
were included in this review. Review and editorial arti-
cles were excluded. Two assessors (OJ, RB) independ-
ently screened each paper and agreement between the
two reviewers were required for an article to be included
in this review. A total of 1,490 titles and abstracts were
reviewed, of which 124 full-length articles were selected
for further review. Of those 124 articles, 59 articles
fulfilled the selection criteria. Four of those 59 articles
were then excluded as they were review articles. 55
full-length articles were finally included for critical
evaluation (Additional file 1: Figure S1). A summary
of studies involving driving in patients with PD are
shown in Table 3. Findings were categorized according to
the assessment tool used to determine fitness to drive in
PD patients.
1) Questionnaires and structured interview
Driving assessment by questionnaires is the most
practical method for evaluating fitness to drive if we
aim for a large number of patients in a short period
of time. While this method is potentially cost
effective, it lacks specific information from individual
patients based on the types of questionnaire. Of 55
articles, 14 studies assessed driving ability in PD
patients using various forms of questionnaires being
part of structured interviews [12, 24, 40, 41, 53–62].
Most questionnaires were composed of specific
items that assessed driving performance, driving
risk, and history of car accidents in addition to
parkinsonian symptomatology. Information on
daytime sleepiness and sleep attacks were included
as additional items or inquired from the assessment
with Epworth Sleepiness Scale (ESS), or SCOPA
sleep scales. The main findings of these studies were
consistent in reporting higher risk of car accidents
among PD drivers than normal subjects.
Importantly, most PD drivers also reported more
daytime somnolence and sleep attacks than their
matched controls when evaluated by sleep scales.
The presence of falling asleep while driving was also
found to be a significant predictor of car accidents
[24]. While the risk of sleep attacks was highest with
dopamine agonists, they were reported to be less
with levodopa monotherapy.
Although results of these studies supported
significant driving risk among PD patients, these
findings should not be generalized to imply that all
PD drivers are unsafe. Careful interpretation of
specific scenarios or additional assessment is
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Table 3 Summary of studies involving driving assessment tools in patients with Parkinson’s disease







[12, 53–55, 58, 62]
• PD drivers reported a high
incident of collisions [12, 53,
62]. Patients with higher
disease severity reported
more collisions.
• Up to 21 % of PD drivers gave
up driving soon after diagnosis
was made [12, 53]
• Falling asleep while driving was
a significant pre had found in
PD drivers, and usually related
with dopamine agonist
medications [54, 55, 58]
• Appropriate as a screening
instrument for physicians in
routine clinical practice
Epworth sleepiness scale
[24, 40, 41, 56, 57, 59–61]
• Excessive daytime somnolence
(EDS) and sleep attacks are
more common in PD drivers
than controls [40, 60, 61].
• EDS is associated with
dopamine agonist medications
[56]
• PD drivers scored worse on ESS
score than controls [60, 61]
• Falling asleep while driving a
car was a significant prognostic
factor of car accidents [24, 59]
• ESS is a useful screening
instrument for EDS and sleep
attacks in PD patients. This test
should be performed in PD




Motor assessment Hoehn & Yahr [3, 4, 13, 14,
19–21, 25, 37, 64, 70–75,
77–79, 81, 91]
• Greater HY score correlated
with higher number of
collisions or driving errors [37]
• Greater HY score correlated
with poor driving performance
and a failed result with on-road
tests [21, 25, 75, 77]
• HY scale should be part of the
clinical evaluation in PD
patients who come for fitness
to drive assessment.
UPRDS-motor [13, 14, 19, 20,
23, 25, 37, 64–67, 69–71,
73–80, 82, 91]
• High UPDRS-motor score
correlated with greater of
collision [37]
• High UPDRS-motor score is a
significant predictor of poor
driving performance and fitness
to drive [25, 75, 82]
• UPDRS-motor scale should be
part of the clinical evaluation in
PD patients who come for
fitness to drive assessment.
Rapid pace walk test (RPW)
[75, 88]
• Poor rapid pace walk test
correlated with poor driving
performance [75, 88]
• RPW test may be considered as
an off-road test in PD patients
who come for fitness to drive
evaluation.
• More studies are needed to
confirm its clinical validity.
Webster’s scale [4, 63, 76] • Poor Webster’s scale correlated
with poor driving performance
[4]
• Webster’s scale should be part
of the clinical evaluation in PD
patients who come for fitness
to drive assessment.
Disease duration and/or LEDs
[13, 14, 19, 20, 23, 65–67, 69,
73, 79, 81, 82, 86, 87, 89, 91]
• Disease duration and/or LEDs
did not correlate with driving
performance.
• Disease duration and
medication review should form
part of basic clinical evaluation
in PD patients at every visit.
Cognitive assessment MMSE [3, 13, 14, 20, 21, 25,
37, 65, 66, 69–73, 75, 77–79,
82, 85–88]
• Poor MMSE score correlated
with higher number of
collisions [37]
• Poor MMSE scores correlated
with poor driving performance.
[86, 88]
• MMSE should be part of the
clinical evaluation in PD
patients who come for fitness
to drive assessment.
Trial A&B making test [13, 20,
21, 67–69, 72–75, 77, 78, 80,
82–84, 86, 87]
• Poor performance on Trail A&B
making test correlated with
poor driving performance and
more driving errors [13, 67, 69,
75, 80, 83, 86]
• Neurocognitive tests should be
considered in PD patients with
cognitive complaints who
come for fitness to drive
assessment.
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generally recommended before final
recommendation is made on individual patient.
2) Off-road testing battery
A number of clinical tools were implemented as part
of the off-road testing battery to assess driving-
related skills in PD on motor, cognitive, and visual
functions (Table 2). In all studies involving off-road
tests, they were conducted as part of the evaluation
panel together with one of the other assessment
methods, including driving simulators, on-road tests,
and naturalistic driving test. Significant correlations
were observed between a set of motor and cognitive
assessment and a number of collisions and poor
driving performance as detailed in Table 3. The
recommendations of these studies include Hoehn
and Yahr (HY) staging and section III of Unified
Table 3 Summary of studies involving driving assessment tools in patients with Parkinson’s disease (Continued)
Complex figure test
[13, 20, 25, 83, 84]
• Poor performance on complex
figure test correlated with poor
driving performance. [13, 83, 84]
• Neurocognitive tests should be
considered in PD patients with
cognitive complaints who
come for fitness to drive
assessment.
Block design test [68, 83, 86]
[84],
• Poor performance on block
design tests correlated with poor
driving performance [84, 86]
• Neurocognitive tests should be
considered in PD patients with
cognitive complaints who come
for fitness to drive assessment.
Dot cancellation test
[74, 76, 78]
• Poor performance on Dot
cancellation test correlated with
decreased driving ability [74, 76]
• Neurocognitive tests should be
considered in PD patients with
cognitive complaints who come
for fitness to drive assessment.
Visual assessment UFOV [13, 19, 25, 68, 73–75,
78, 79, 82, 84, 87, 89, 91]
• Decreased UFOV score
correlated with poor driving
performance and higher collision
risk [13, 25, 75, 80, 82, 84]
• Visual assessment with UFOV
may be considered in PD
patients who come for fitness
to drive assessment.
Pelli-Robson contrast
sensitivity [23, 78, 79, 89, 91]
• Low-contrast visibility
conditions imposed significant
hazard for PD drivers.
• More studies are needed to
confirm the validity of this test.
Visual acuity [19, 20, 74, 75,
78, 91]
• Poor visual acuity limits driving
ability in PD patients.
• Visual acuity should be
performed in PD patients who
come for fitness to drive
assessment.
Driving simulators Driving simulators (16
papers)
Driving simulators [4, 19, 20,
37, 63–74]
• PD drivers committed more
driving errors than controls
[4, 37, 63],
• Greater PD disease severity
determined with UPDRS or HY
scale are correlated with poor
driving performance [4]
• Poor performance on cognitive
test especially with executive
testing and visual attention
correlated with more driving
errors [20, 37]
• Driver assistance improved the
driving performance in PD
patients [69, 72]
• Physicians should consult local
authorities on PD patients who
may be unfit to drive for further
evaluation.
4. Driving skill test On-road tests
(24 papers)
On-road tests [3, 13, 14, 19,
21, 25, 74–91]
• PD drivers performed worse on
on-road tests when compared
to controls [3]
• Greater PD disease severity
determined with UPDRS or H&Y
scale correlated with poor
driving performance [3, 82, 89]
• Poor performance on cognitive
and/or visual tests affect driving
ability in PD patients [25, 82]
• Physicians should consult local
authorities on PD patients who






• PD drivers committed more
errors, as shown by slow brake
response time and slow
reaction time [23]
• Physicians should consult local
authorities on PD patients who
may be unfit to drive for further
evaluation.
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Parkinson’s Disease Rating Scale (UPDRS) for the
assessment of motor function, the Useful Field of
View (UFoV) for the evaluation of vision, and
Mini-Mental Status Examination (MMSE), Trail
A&B Making test, complex figure test, and block
design test for cognitive assessment (Table 3).
Similar recommendations were observed in a recent
evidence-based review on driving in PD that include
a subset of cognitive and visual assessments
(e.g., UFoV, complex figure test) as probably
predictive of driving performance [22].
The impairment of motor, visual, and cognitive
functions in PD patients as identified by these
off-road tests was associated with poor driving
performance, and higher number of collisions
(Table 3). The utility of these off-road tests probably
represents a set of screening tools that is available
for physicians to perform during the initial
assessment so it can provide them with objective
information on motor, visual, and cognitive
performances of individual patients before
undergoing more detailed driving test. More studies
are needed to determine whether off-road tests are
comparable to on-road tests in identifying unsafe PD
drivers. At present, in a practical sense, most of the
off-road tests (e.g., motor and cognitive assessments)
can be utilized by physicians on the spot in the
outpatient setting when suspecting any PD patients
to be unsafe drivers. In addition, they are widely
available in most practices and medical centers,
representing the first-tier of test battery for a
determination of driving competency. Whether
off-road tests are adequate on their own in identifying
most if not all unsafe drivers (without a need to be
confirmed by additional on-road tests) remain to be
confirmed in future studies. Future studies are needed
to determine cutpoints of risk factors with off-road
performance (e.g., sensitivity, specificity, negative
predictive value, and positive predictive value) and
prospective crash risk. However, some of these
off-road tests have been implemented in certain
guidelines. For example, the recent consensus
statements have adopted several findings of the
off-road tests towards a recommendation of cessation
of driving or additional evaluation by driving
authorities [34].
3) Driving simulator
Out of 55 articles, 16 articles assessed driving ability
in PD patients using a driving simulator [4, 19, 20,
37, 63–74] (Table 3). Among these articles, two
studies combined a driving simulator and an
on-road test on the same target population [19, 74].
When tested with simulators under different driving
conditions (high-contrast and low-contrast visibility
conditions), PD patients committed more driving
errors than controls, including delayed reaction
time, steering accuracy, impaired vehicle control, red
light violations, and higher number of collisions,
[4, 63, 65–68, 71]. Moreover and as compared to
controls, PD patients approached signals with a
slower speed, drove more slowly around curves, and
had more difficulty maintaining lane position around
curves [66]. Poor driving performance in simulator
was found to correlate with disease severity and
executive functions, as determined by Webster,
UPDRS, and HY scales [4, 37, 68–71]. Importantly,
performance deficits in driving simulators were
identified even in patients with mild-moderate
severity when they were challenged under dual-task
conditions [65, 66, 70].
In general, driving simulator is a screening test
option for at-risk driver that yields data and findings
that traditional evaluation techniques cannot
produce. In addition, simulators can also be used to
determine predictors of driving performance that
cannot be tested on the road due to ethical, safety,
and practical concerns (e.g., night, high volume
traffic, poor weather conditions) [22]. Predictors
identified on the simulator can be further tested in
the on-road tests [22]. In cases with poor performance
from driving simulator, the physician should advise
the patients to undergo an on-road test organized by
a driver licensing authority.
4) Driving skill tests
4.1)On-road tests
An on-road test is capable of identifying tactical
errors made when patients maneuver the
vehicle in response to demands of the changing
environment, in addition to strategic and
operational errors made while driving. PD drivers
demonstrated significantly higher on-road test
failure rate and significantly more on-road driving
errors than controls [75]. Out 55 articles, 24
articles assessed driving ability by on-road tests
[3, 13, 14, 19, 21, 25, 74–91]. In addition to
deficits identified by driving simulators, PD
drivers had significantly more errors than
controls for observing blind spots, backing up,
parking, and negotiating traffic lights [14]. Other
problems identified among PD drivers included
use of mirrors and delays in decision-making and
judgments [81]. Similar to findings from
driving simulator-based assessments, PD drivers
demonstrated poorer performance in the
concurrent task of detecting roadside targets than
controls [91]. What is truly considered poor
driving performance can be difficult to interpret
in these studies since not all studies provided
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pass/fail outcomes on the on-road tests [22]. One
study that utilized CARA assessment as the main
outcomes of pass (fit to drive without restriction)
and fail (fit to drive with restrictions and unfit to
drive) in 80 PD patients identified approximately
one out of four patients failed the on-road test [19].
Following a brief report showing that PD drivers
with EDS may exhibit driving errors in driving
simulators, five out of 21 PD drivers with
self-reported EDS on ESS underwent an on-road
test [64, 79]. Although neither EDS nor
antiparkinsonian medications were associated
with poor on-road driving performance, this
study merits further investigation involving a
larger number of patients with a more stringent
methodology.
4.2)Naturalistic driving test
From our systematic review, three studies used
the naturalistic driving method to examine
whether PD symptoms (motor, cognitive, vision,
sleepiness, depression) were associated with
driving performance [23, 92, 93]. Naturalistic
driving vehicles are equipped with several small
cameras and sensors that continuously and
inconspicuously register vehicle maneuvers,
driver behavior, and external conditions.
Compared to controls, PD drivers exhibited
increased driving risks, as shown by slower brake
response time, and slower reaction time, as well
as having significantly more cognitive and
depressive symptoms. In addition, PD drivers who
had a poor perception of their health were more
likely to restrict their driving due to worsening
PD symptoms and more likely to have more
noticeable declines in multiple driving-related
abilities. Naturalistic driving provides insight into
everyday driver behavior. This method facilitates
observation and analysis of interrelationships
between the driver and the vehicle, road, and
other traffic in normal situations, conflict
situations, and crashes.
Conclusion
Due to the progressive nature of PD, as well as the het-
erogeneity of symptoms that fluctuate on a daily basis,
adequate monitoring for fitness to drive is of paramount
importance to ensure the safety of both PD patients and
others on the road. A fitness to drive evaluation is
needed to discern individuals with PD who can continue
to drive safely from those who are likely to endanger
themselves and others. However, the extent that physi-
cians should be involved in the evaluation process, and
make related recommendations remains unclear. Our
systematic review indicates that not all the tools are
available in routine clinical practice. When considered
only questionnaires, structured interviews and off-road
testing battery, most of the tests are part of standard
clinical examination (e.g., HY, MMSE, UPDRS-motor)
and can easily be tested on PD patients in clinical prac-
tice. The information obtained from these tests (e.g.,
cognitive status, severity of motor symptoms) provides
important background information to local authorities
when patients are proceeded to undergo additional tests,
for example on-road tests. The situation is more challen-
ging with driving simulators, on-road tests, and natural-
istic driving because there are differences between
studies involving these tools in technical characteristics,
primary outcomes, and a lack of validity. These concerns
probably limit the implementation of a uniform guide-
line on how these tests could be utilized as part of a for-
mal assessment of driving competency in PD patients.
Moreover, physicians may not be aware of the details of
these tests and find it difficult to recommend them to
PD patients. While on-road tests are considered by some
as the reference standard, these tests are not as yet im-
plemented or recommended by recent consensus state-
ment and evidence-based review [22, 34, 43]. However,
on-road tests are usually part of the formal assessment
imposed by driving authorities. In certain situations,
physicians may be able to refer patients directly for an
on-road test or naturalistic driving if they are locally
available and patients are deemed to be fit to undergo
such tests by local authorities. Direct referral to an on-
road test may be particularly useful when there are
conflicting opinions between the patient and family
members about their safety. We recommend that physi-
cians consult their driving authorities for advice on add-
itional tests if concerns are observed from structured
interview and off-road tests.
Based on experiences described in related reports, it
appears that physicians are at the forefront when the
issue of driving ability is raised by patients or their fam-
ily members (Fig. 2). It is, therefore, necessary for physi-
cians to have and conduct a risk assessment protocol
that can evaluate if his/her patients are able to safely
control and maneuver a motor vehicle. In addition to
clinical assessments specific to PD, physicians should
have sufficient knowledge about the functional capacity
of the driver that is based on the minimum functional
requirement for safe driving. In clear-cut or advanced-
stage PD patients, assessment is not a problem since
driving cessation is normally agreeable by all parties.
Alternative modes of transportation should be explored
for these patients. The problems tend to arise in those
PD patients that are not clear-cut or advanced-stage in
which careful evaluation and informed judgment on the
part of treating physician is required. As a result, physi-
cians are likely to make their judgment based on
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physical assessment rather than driving assessments, as
they do not know how to undertake or participate in this
kind of assessment. Given that most physicians lack
basic knowledge and the formal training necessary to
make a recommendation regarding which PD patients
can safely operate a motor vehicle, we propose that this
training be incorporated into the medical curriculum, as
well as into continuing professional development pro-
grams [36]. The focus of the training should be on the
following aspects: 1) the impact of PD for safe driving
ability, 2) the basic knowledge on the legal requirement
for PD patients on fitness to drive, 3) ability to treat,
manage and monitor the individual’s PD condition with
ongoing consideration of their fitness to drive, and 4)
when to inform driving authorities when fitness to drive
requires notification but an individual cannot or will not
notify the local authority. At the same time, there is a
need for more research to develop validated tools that can
be implemented by licensing authorities as objective mea-
sures to determine fitness to drive that are specific to PD.
Driving safety is an important public health issue that
needs better-defined legal and medical guidelines, both
generally and specific to PD drivers. The release of recent
consensus statements on driving with PD in Canada is a
promising development that should be expanded to other
regions [34]. In addition, local guidelines should be com-
municated to physicians regarding assessment and report-
ing of PD drivers to the appropriate local agency when
patients are deemed potentially unsafe. Once a patient is
reported as unsafe, a well-defined course of action should
be undertaken, including formal retesting for driver recer-
tification by licensing authorities that used validated
objective assessment tools (Fig. 2). The establishment and
implementation of consistent and specific guidelines
would help alleviate the conflicts experienced by physi-
cians regarding patient confidentiality and help promote
and improve public safety. PD drivers who are borderline
in their driving competency should be offered driving re-
habilitation or retraining that focuses on operational and
tactical skills, as well as visual, cognitive, and motor func-
tions so they can be reassessed for licensing if their skills
improve [94].
Fig. 2 The diagram illustrating the role of physician in the determination of fitness to drive in patients with Parkinson’s disease (PD). In PD drivers
who are deemed to be fit to drive, they can continue driving with an unconditional license. In cases where PD drivers were identified from
‘clinical red flags’ to be unsafe, they should undergo an off-road test which is composed of three major components to determine an individually
driving ability, including motor, cognitive, and visual assessments. Some of these assessments (e.g., HY, MMSE) are part of standard clinical
examination which can be performed by treating physicians during routine consultations. However, others (e.g., UFoV test, Pelli-Robson contrast
sensitivity) may not be available locally and require additional referral. For PD drivers who passes an off-road test, they can continue driving as
usual, but with a recommendation of annual evaluation. For PD driver who fails an off-road test, a physician might request for further evaluation
for fitness to drive by using an on-road test, driving simulator, or naturalistic driving depending on patient’s conditions, availability, local
guidelines, and regulations. HY: Hoehn & Yahr; MMSE: Mini-Mental Status Examination; UFoV: Useful Field of View
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